| 000 | 00000nam##2200000za#4500 |
| 001 | 9.670995 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210615125854 |
|---|
| 007 | ta |
|---|
| 008 | 150407|2009||||xxc||||| f|0| 0 eng|d |
|---|
| 020 | |a978-0-662-06565-4 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 041 | |aeng |
|---|
| 041 | |afre |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aPH4-51/2009 |
|---|
| 110 | 1 |aCanada.|bPolicy Research Initiative. |
|---|
| 245 | 10|aEconomic valuation of mortality risk reduction : |breview and recommendations for policy and regulatory analysis / |c[by] Lauraine G. Chestnut, Paul De Civita. |
|---|
| 260 | |aOttawa - Ontario : |bPolicy Research Initiative |c2009. |
|---|
| 300 | |aEnglish text, 64p. : |breferences, tables ; |c28 cm. |
|---|
| 500 | |a"PRI Project, Regulatory Strategy". |
|---|
| 520 | 3 |aA review of the available literature on the value of a statistical life (VSL). The VSL is used in economic evaluations (e.g. benefit-cost analysis) of proposed regulations and policies that affect human health to help understand the resulting benefits or damages. Existing primary studies and synthesis analyses are reviewed with a focus on recommending appropriate central, low and high values for Canadian public policy. Canadian as well as U.S. studies comprise the majority of the studies reviewed. A considerable amount of effort was placed on discussing the range of adjustments that theoretically can be made to adjust the values for age, income and cause of the premature mortality. |
|---|
| 563 | |aSpiral binding |
|---|
| 590 | |a09-14|b2009-04-03 |
|---|
| 720 | 1 |aG. Chestnut, Lauraine |
|---|
| 720 | 1 |aDe Civita, Paul |
|---|
| 776 | 0#|tÉvaluation économique de la réduction des risques de mortalité : |w(CaOODSP)9.636217 |
|---|
| 776 | 0#|tEconomic valuation of mortality risk reduction : |w(CaOODSP)9.691923 |
|---|
| 792 | |tÉvaluation économique de la réduction des risques de mortalité : |efre|w(CaOODSP)9.670996 |
|---|